Evidence map›Paper›PMID 39610773›Full record

ArticleWorld journal of gastroenterology2024

Role of different examination methods in colorectal cancer screening: Insights and future directions.

Qiu-Ning Liu, Yang Ye, Xiao-Qiang Jia

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of gastroenterology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Qiu-Ning LiuGraduate School, Beijing University of Chinese Medicine, Beijing 100029, China.
Yang YeDepartment of Traditional Chinese Medicine, Peking University Third Hospital, Beijing 100191, China. yeyang89@bjmu.edu.cn.
Xiao-Qiang JiaDepartment of Anorectal, Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine, Beijing 100091, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer is a malignant tumor with the third and second highest incidence and mortality rates worldwide, and its mortality rate is increasing annually. Colorectal cancer evolves gradually over a long period of time. The evolving process from colorectal adenoma to colorectal cancer takes approximately 10-15 years, providing a sufficiently long "window period" for early screening and diagnosis of colorectal cancer. The recurrence and mortality rates can be controlled at a low level with an early intervention. Metaxas

Indexed as

ColonoscopyColorectal NeoplasmsEarly Detection of CancerHumansMass ScreeningOccult BloodPredictive Value of TestsColorectal cancerEarly screening of tumorsNon-invasive liquid tissue biopsyResearch progress

Identifiers

PMID39610773
PMCPMC11580609

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.